Harshabad Singh, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Neoplasms | 9 | 2024 | 5446 | 1.300 |
Why?
|
Barrett Esophagus | 2 | 2021 | 494 | 1.140 |
Why?
|
Carcinoma, Pancreatic Ductal | 5 | 2023 | 1759 | 1.030 |
Why?
|
Leucovorin | 2 | 2024 | 644 | 0.980 |
Why?
|
Receptor, erbB-2 | 3 | 2024 | 2599 | 0.960 |
Why?
|
Stomach Neoplasms | 2 | 2024 | 1481 | 0.860 |
Why?
|
Adenocarcinoma | 6 | 2024 | 6360 | 0.860 |
Why?
|
fms-Like Tyrosine Kinase 3 | 3 | 2011 | 494 | 0.850 |
Why?
|
Fluorouracil | 2 | 2024 | 1652 | 0.790 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 155 | 0.740 |
Why?
|
Colorectal Neoplasms | 5 | 2025 | 6966 | 0.740 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2025 | 11872 | 0.740 |
Why?
|
Deoxycytidine | 2 | 2024 | 886 | 0.720 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2023 | 631 | 0.690 |
Why?
|
Paclitaxel | 2 | 2024 | 1728 | 0.590 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1761 | 0.540 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 632 | 0.540 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 706 | 0.540 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1885 | 0.500 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2047 | 0.490 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 190 | 0.470 |
Why?
|
Mutation | 9 | 2024 | 30211 | 0.470 |
Why?
|
Esophageal Neoplasms | 1 | 2024 | 1661 | 0.450 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1621 | 0.430 |
Why?
|
Genes, ras | 1 | 2015 | 656 | 0.410 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1608 | 0.410 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2014 | 305 | 0.390 |
Why?
|
Genetic Testing | 1 | 2024 | 3591 | 0.360 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2014 | 614 | 0.360 |
Why?
|
Metaplasia | 2 | 2021 | 326 | 0.350 |
Why?
|
ras Proteins | 1 | 2015 | 1054 | 0.340 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2010 | 249 | 0.320 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2227 | 0.310 |
Why?
|
Stem Cells | 1 | 2021 | 3535 | 0.300 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5693 | 0.250 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2011 | 3626 | 0.250 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1366 | 0.230 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2016 | 2186 | 0.220 |
Why?
|
Angiopoietin-2 | 1 | 2025 | 186 | 0.220 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1596 | 0.210 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1907 | 0.200 |
Why?
|
Inflammation | 1 | 2022 | 10869 | 0.200 |
Why?
|
Esophagogastric Junction | 1 | 2024 | 350 | 0.200 |
Why?
|
Transcription Factors | 1 | 2021 | 12158 | 0.200 |
Why?
|
Albumins | 1 | 2024 | 577 | 0.190 |
Why?
|
Graft Rejection | 1 | 2014 | 4498 | 0.180 |
Why?
|
SOX9 Transcription Factor | 1 | 2021 | 145 | 0.180 |
Why?
|
Anus Neoplasms | 1 | 2024 | 336 | 0.170 |
Why?
|
Gene Amplification | 1 | 2024 | 1088 | 0.160 |
Why?
|
Humans | 29 | 2025 | 767040 | 0.160 |
Why?
|
Immunohistochemistry | 2 | 2024 | 11063 | 0.160 |
Why?
|
Neutropenia | 1 | 2023 | 892 | 0.150 |
Why?
|
Treatment Outcome | 6 | 2025 | 65295 | 0.150 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1741 | 0.150 |
Why?
|
Aged | 8 | 2025 | 171319 | 0.130 |
Why?
|
Prognosis | 4 | 2024 | 29963 | 0.130 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2016 | 75 | 0.130 |
Why?
|
Middle Aged | 9 | 2025 | 223233 | 0.120 |
Why?
|
Epigenomics | 1 | 2021 | 959 | 0.120 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1349 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 957 | 0.120 |
Why?
|
Hypertension, Malignant | 1 | 2014 | 17 | 0.120 |
Why?
|
Male | 13 | 2025 | 364203 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2428 | 0.120 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2014 | 104 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6513 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2058 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8628 | 0.110 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4114 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2429 | 0.100 |
Why?
|
Female | 11 | 2025 | 396660 | 0.100 |
Why?
|
Cell Lineage | 1 | 2021 | 2575 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1639 | 0.100 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2012 | 0.100 |
Why?
|
Mice | 5 | 2024 | 81912 | 0.090 |
Why?
|
Genomics | 2 | 2024 | 5924 | 0.090 |
Why?
|
Adult | 8 | 2025 | 223317 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 1 | 2023 | 4522 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18063 | 0.090 |
Why?
|
Inverted Repeat Sequences | 1 | 2010 | 59 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2011 | 6844 | 0.090 |
Why?
|
Tandem Repeat Sequences | 1 | 2011 | 183 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2538 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2824 | 0.080 |
Why?
|
Subclavian Artery | 1 | 2009 | 138 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2014 | 812 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9532 | 0.080 |
Why?
|
Leukemia, Myeloid | 1 | 2011 | 693 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4049 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2025 | 4903 | 0.070 |
Why?
|
Animals | 6 | 2024 | 168965 | 0.070 |
Why?
|
Aortic Coarctation | 1 | 2009 | 278 | 0.070 |
Why?
|
Fibrinogen | 1 | 2010 | 892 | 0.070 |
Why?
|
Survival Rate | 2 | 2011 | 12823 | 0.070 |
Why?
|
Phenotype | 2 | 2023 | 16718 | 0.070 |
Why?
|
Neoplasms | 1 | 2015 | 22350 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2118 | 0.070 |
Why?
|
Transplantation, Homologous | 1 | 2014 | 4838 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2021 | 11657 | 0.060 |
Why?
|
Angiopoietin-1 | 1 | 2025 | 132 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 856 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1626 | 0.060 |
Why?
|
Vascular Malformations | 1 | 2009 | 469 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2381 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 2457 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 116 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8504 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2024 | 81659 | 0.050 |
Why?
|
HT29 Cells | 1 | 2021 | 187 | 0.050 |
Why?
|
Genes, APC | 1 | 2021 | 144 | 0.050 |
Why?
|
Signal Transduction | 2 | 2015 | 23621 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3944 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8048 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39317 | 0.040 |
Why?
|
Risk | 1 | 2010 | 9606 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2016 | 59548 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10092 | 0.040 |
Why?
|
Young Adult | 3 | 2016 | 59980 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 615 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13650 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1854 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2025 | 3738 | 0.030 |
Why?
|
United States | 1 | 2024 | 72971 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1903 | 0.030 |
Why?
|
Prospective Studies | 2 | 2024 | 54886 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6106 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2023 | 6507 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2715 | 0.030 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2014 | 131 | 0.030 |
Why?
|
DNA Repair | 1 | 2021 | 2050 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2902 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2341 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 14098 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7210 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 440 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2011 | 655 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9551 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12986 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10455 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 22361 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2412 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2009 | 1320 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1429 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41718 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18989 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9513 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 17097 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18330 | 0.010 |
Why?
|